Impacts of tacrolimus and glucocorticoids on peripheral blood T and B lymphocyte subsets in myasthenia gravis
Compared with patients receiving glucocorticoid therapy, those treated with tacrolimus exhibited significantly lower levels of peripheral CD3<sup>+</sup>CD4<sup>+</sup> T cells after treatment. These findings provide insight into the differential immunomodulatory effects of these therapies in MG.
Authors
- Huanhuan Song (ORCID: https://orcid.org/0009-0001-5447-8857)
- Xuan Wu (ORCID: https://orcid.org/0009-0009-2175-3953)
- Wei Chen (ORCID: https://orcid.org/0000-0003-2551-4916)
- Guorong Xu
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-10-15
- DOI
- https://doi.org/10.3389/fimmu.2025.1667799
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Fujian Province